This is not the latest version of this item. The latest version can be found here.
Beneficiary cost sharing under Canadian provincial prescription drug benefit programs
| dc.contributor.author | Grootendorst, Paul. | en_US |
| dc.contributor.author | Centre for Health Economics and Policy Analysis | en_US |
| dc.coverage.spatial | Canada | en_US |
| dc.coverage.spatial | Canada | en_US |
| dc.coverage.spatial | Canada | en_US |
| dc.coverage.spatial | Canada | en_US |
| dc.coverage.spatial | Canada | en_US |
| dc.coverage.spatial | Canada | en_US |
| dc.date.accessioned | 2015-04-14T14:42:05Z | |
| dc.date.available | 2015-04-14T14:42:05Z | |
| dc.date.issued | 1999 | en_US |
| dc.description | Paul Grootendorst. | en_US |
| dc.description | Includes bibliographical references (p. 15). | en_US |
| dc.format.extent | 38 p. : ill. ; 28 cm. | en_US |
| dc.identifier.uri | http://hdl.handle.net/11375/17165.1 | |
| dc.publisher | McMaster University, Centre for Health Economics and Policy Analysis | en_US |
| dc.relation.ispartofseries | CHEPA working paper series no. 99-10 | en_US |
| dc.subject | Insurance, Pharmaceutical Services | en_US |
| dc.subject | economics | en_US |
| dc.subject | Insurance, Pharmaceutical Services | en_US |
| dc.subject | Aged | en_US |
| dc.subject | Prescription Drugs | en_US |
| dc.subject | economics | en_US |
| dc.subject | Prescription Fees | en_US |
| dc.subject | Cost Sharing | en_US |
| dc.subject | Cost-Benefit Analysis | en_US |
| dc.subject | Drug Costs | en_US |
| dc.title | Beneficiary cost sharing under Canadian provincial prescription drug benefit programs | en_US |
| dc.type | text | en_US |